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Abstract
Disease detection in historical samples currently relies on DNA extraction and amplification, or immunoassays. These
techniques only establish pathogen presence rather than active disease. We report the first use of shotgun proteomics to
detect the protein expression profile of buccal swabs and cloth samples from two 500-year-old Andean mummies. The
profile of one of the mummies is consistent with immune system response to severe pulmonary bacterial infection at the
time of death. Presence of a probably pathogenic Mycobacterium sp. in one buccal swab was confirmed by DNA
amplification, sequencing, and phylogenetic analyses. Our study provides positive evidence of active pathogenic infection
in an ancient sample for the first time. The protocol introduced here is less susceptible to contamination than DNA-based or
immunoassay-based studies. In scarce forensic samples, shotgun proteomics narrows the range of pathogens to detect
using DNA assays, reducing cost. This analytical technique can be broadly applied for detecting infection in ancient samples
to answer questions on the historical ecology of specific pathogens, as well as in medico-legal cases when active
pathogenic infection is suspected.
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tissues, use a small number of targeted antibodies, and are prone to
both false positives and false negatives [10,11]. Proteomics
approaches can identify and quantify proteins directly, and offer
three distinct advantages in archeological and forensic research [12].
First, proteins can potentially outlast DNA by thousands to millions
of years [13,14], pushing back the time frame for detection of
responses to infection. Second, protein detection does not rely on
amplification, so there is less susceptibility to contamination than in
PCR [15]. Third, a broad spectrum of proteins can be characterized
from small samples, resulting in a more resolved picture of immune
response than from immunoassays [16]. In this paper, we present
methods for obtaining proteomic-quality samples from 500-year old
Andean mummies, and results documenting immune response in
these ancient human samples. Our results show that shotgun
proteomic applications complement results from forensic DNA
analyses by providing evidence of active infection and pointing to the
pathogens triggering observed immune responses.

Introduction
Over the last decade, forensic techniques relying on ancient DNA
extraction and PCR amplification have provided critical evidence to
resolve longstanding historical questions, such as uncovering
pathologies linked to the early death of Tutankhamen [1], or
identifying the presence of the pathogen Yersinia pestis in bodies
excavated from medieval cemeteries [2,3]. Because extraneous
DNA can be easily amplified during PCR, forensic applications rely
on strict controls to avoid false positives [4,5]. When used to infer
infection in historical samples, DNA techniques can confirm
pathogen presence but cannot positively infer disease because a
pathogen could be present without causing infection [6,7,8]. Such
applications are particularly valuable in an archeological context, in
which differentiating between natural and deliberate causes of death
can significantly change the interpretation of a historical event [1,2].
Detection of a pathogen, however, is necessary but not sufficient to
determine disease because the pathogen could be present without
causing infection [6,7,8].
Detecting the immune reaction to the pathogen in the host
provides positive evidence of active pathogenic infection [9].
Existing methods, such as antibody-binding immunoassays, are ill
suited for archeological applications because they require fresh
PLoS ONE | www.plosone.org

Methods
Archaeological Context
In 1999, a team of archaeologists led by Johan Reinhard and
Constanza Ceruti, uncovered the site of three burials 25 m from
1
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swabs and the fabric were cut off and placed in separate lowprotein binding 1.5 ml polypropylene microfuge tubes. All sample
tubes received 50 mM NH4HCO3 sufficient to cover the sample
and incubated at 23uC for 10 min followed by 10 min submersion
in a bath sonicator at 23uC. The samples were centrifuged for
5 min at 16,000 G and 23uC, and the supernatant transferred to
fresh tubes. The moist fabric and cotton were transferred to 500-ml
polypropylene tubes perforated with a 22-gauge needle hole in the
bottom. The tubes were place into the original 1.5 ml tubes and
the combined tubes centrifuged for 1 min at 16,000 G. The
passed-through buffer was combined with the removed supernatants. The tubes containing the supernatant and pass-through
were centrifuged at 16,000 G for 5 min and the resultant
supernatants (,100 ml) transferred to fresh tubes. The volume of
supernatants was reduced to 20 ml using a Speed-Vac, and each
tube subsequently received 20 ml of ACN. The samples were
reduced by the addition of 1 ml of 0.1 M DTT and incubated
30 min at 23uC. The samples were alkylated by the addition of
1 ml of 0.2 M iodoacetamide and incubated for 30 min at 23uC in
the dark. Each tube then received 10 ml of 5X Invitrosol followed
by 1 ml of trypsin at 1 mg/ml. The samples were incubated
overnight at 37uC. Following incubation, the samples were
centrifuged at 16,000 G for 5 min, the supernatants transferred
to fresh tubes, and the volumes reduced to 20 ml in a Speed-Vac.
Each tube received 5 ml of 0.1% TFA and sufficient volume of 2%
(v/v) acetonitrile, 0.2% formic acid to bring the total volume to
,50 ml. Each sample was divided into 3 , 15-ml aliquots. One
aliquot was subjected to immediate mass spectrometry (MS)
analysis, while the others were quick-frozen in liquid N2 and stored
at 280uC.
Fifteen ml of the peptide mixture from each residual sample was
analyzed by automated microcapillary liquid chromatographytandem mass spectrometry on a Thermo LTQ-Orbitrap XL mass
spectrometer. Fused-silica capillaries (100 mm i.d.) were pulled
using a P-2000 CO2 laser puller (Sutter Instruments, Novato, CA)
to a 5-mm i.d. tip and packed with 10 cm of 5-mm Magic C18
material (Agilent, Santa Clara, CA) using a pressure bomb. This
column was then placed in-line with an Eksigent 2D HPLC with
autosampler. The column was equilibrated in buffer A (2%
acetonitrile, 0.1% formic acid), and the peptide mixture was
loaded onto the column using the autosampler. The HPLC
separation at a flow rate of 300 nl/min was provided by a gradient
between Buffer A and Buffer B (98% acetonitrile, 0.1% formic
acid). The HPLC gradient was held constant at 100% buffer A for
5 min after peptide loading, followed by a 30-min gradient from

the 6,739-m summit of Llullaillaco, a high elevation volcano in
the province of Salta, Argentina. The expedition recovered the
preserved bodies of two young children (a 7 year-old boy and a
6-year old girl) and one 15-year old adolescent girl known as
‘‘the Maiden’’. The three children had been sacrificed to
Pachamama, the earth goddess, in the ritual of Capacocha
[17,18,19]. The outstanding condition of the mummies (fig. 1)
was the result of the combination of freezing temperature, mild
humidity, anaerobic environment and the presence of natural
disinfectants. The bodies were buried about 50 cm underground,
and the empty space within the tombs was packed with volcanic
ash. The ash inhibited the growth of decomposing bacteria and
fungi, and acted as a barrier to moisture, protecting the bodies
from external humidity while preserving internal moisture. This
atmosphere provided the conditions for the subcutaneous fat of
the bodies to transform into soap in a process called adipocere
[19,20]. Finally, a layer of packed snow rendered the tombs
airtight shortly after their closing. As a result, the bodies were
exceptionally preserved and provided more high-quality physical
evidence for their state at the time of death than comparable
finds from that period anywhere in the world.

Sampling
All three Llullaillaco mummies are preserved at Museum of
High Mountain Archaeology (MAAM) in Salta (Argentina). They
are in airtight, self-contained capsules and maintained at 220uC,
in a mix of liquid nitrogen vapor and 2% oxygen. Sampling took
place in the cold laboratory adjacent to the mummies’ repository,
at 25uC. We sampled a small, blood-soaked piece of cloth from
the boy’s cloak, against which his mouth rested. We took four
contact mouth swabs from the lips of the Maiden and the boy,
since the lips of both presented blood and saliva deposits. The
mummy of the young girl (‘‘La Niña’’) showed signs of having
been struck by lightning (fig. 1) and was not sampled. All samples
were placed dry in individual sterile and sealed vials to prevent
contamination. They were kept dry at room temperature to
avoid any oxidative or hydrolytic lesions to the DNA. The
samples were shipped and maintained dry until analyses.

Proteomic Sample Preparation and Analysis
Three samples were obtained from the mummies: 1) a 3 mm2
piece of fabric from the boy, 2) a cotton swab from the lips of the
boy, and 3) a cotton swab from the lips of the Maiden. All were
processed with the same protocol. The excised tips of the cotton

Figure 1. The children of Llullallaico. a) La Doncella (the Maiden); b) El Niño (the Boy); and c) La Niña (the Girl).
doi:10.1371/journal.pone.0041244.g001
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to the sample from the boy. A similar comparison of other proteins
should not be significant.

5% buffer B to 40% buffer B. Then, the gradient was switched
from 40% to 80% buffer B over 5 min and held constant for
3 min. Finally, the gradient was changed from 80% buffer B to
100% buffer A over 1 min, and then held constant at 100% buffer
A for 15 more minutes. The application of a 1.8-kV distal voltage
electro-sprayed the eluted peptides directly into the mass
spectrometer equipped with a custom nanoLC electrospray
ionization source. Full mass spectra (MS) were recorded on the
peptides over a 400–2000 m/z range at 60,000 resolution (at m/z
400), followed by five tandem mass (MS/MS) events sequentially
generated in a data-dependent manner on the first, second, third,
fourth and fifth most intense ions selected from the full MS
spectrum (at 35% collision energy). Mass-spectrometer scan
functions and HPLC solvent gradients were controlled by the
Xcalibur data system (ThermoFinnigan, San Jose, CA).
Tandem mass spectra were extracted from raw files with the
program RawXtract (fields.scripps.edu). The spectra were
searched against a human protein database containing 87,061
protein sequences downloaded as FASTA-formatted sequences
from EBI-IPI (database version 3.68) [21] and 54 common
contaminant proteins, for a total of 87,115 target database
sequences. To calculate confidence levels and false positive rates,
a decoy database containing the reverse sequences of 87,115
proteins appended to the target database [22] and the SEQUEST
algorithm [23] was used to find the best matching sequences from
the combined database. The peptide mass search tolerance was set
to 50 ppm. A static modification on cysteines of 57.02146 Da was
included. No enzymatic cleavage conditions were imposed on the
database search, so the search space included all candidate
peptides whose theoretical mass fell within the mass tolerance
window, despite their tryptic status. DTASelect [24] was used to
filter good peptide matches from the SEQUEST result. Table S1 a
full list of the proteins and peptides detected.

DNA Extraction, Amplification, Sequencing and Analyses
All DNA extractions were conducted in a laboratory that
undergoes regular decontamination with UV-irradiation and
hypochlorite treatment. Each sample extraction was conducted
separately to prevent cross-contamination. All extractions were
performed in a BSL-II cabinet, which was UV-irradiated for 1
hour prior to each sample extraction. All consumables, including
pipettor tips, micro-centrifuge tubes and collection tubes as well as
the small equipment such as pipettors were UV-irradiated in a UV
crosslinker for 20 minutes at 12006100 mJ/cm2. Gloves were also
changed between every step of the extraction to prevent
contamination. Mock DNA extractions and control blank PCRs
were performed for every DNA assay in the laboratory and
screened for contamination.
Swab sample extraction protocol 1: two swab tips, one
each from the Maiden and the boy were placed in 1.2-ml microcentrifuge tubes, and DNA was extracted using a modified QIAmp
extraction protocol. The swab tips were lysed at 56uC for 60
minutes in 190 ml of QIAmp micro kit ATL buffer (Qiagen Inc.,
Valencia, CA). We then added 200 ml of AL buffer with 1 ml of
Carrier RNA, and incubated the solution at 95uC for 5 minutes in
a thermal mixer shaking at 900 rpm. All swab tips were then
removed from the micro-centrifuge tubes, and the solution was
purified using the QIAmp micro-columns. The samples were
eluted using PCR-grade water and stored at 4uC prior to
amplification.
Swab sample extraction protocol 2: small subsamples
(1 mm3) of the two swabs from the Maiden and the boy were
processed using the ZyGEM forensicGEM Saliva kit (ZyGEM
corp. ltd., Solana Beach, CA). The subsamples were washed with
DNA-free water, following the forensicGEM saliva kit protocol.
The eluates were then transferred to a 0.2 mL PCR clean tube
with 10 ml of 10x ZyGEM buffer, 69 ml of DNA-free water and
1 ml of forensicGEM gold buffer. The solution was incubated at
75uC for 15 minutes, then at 95uC for 5 minutes. The samples
were then ready for amplification.
A reading of the final DNA concentration for all samples using
the Thermo Scientific NanoDrop 1000 spectrophotometer
(Thermo Fisher Scientific, ltd., Waltham, MA) was performed to
ensure sufficient DNA yield prior amplification.
We used 4 different sets of primers in PCR amplifications from
all swab samples, targeting the 16S rRNA, MTP40 and hsp65
genes of Mycobacterium sp., Mycobacterium avium and Mycobacterium
tuberculosis (see table 1) [30,31]. Amplifications were carried out in
25-ml volumes using the PuReTaq Ready-To-Go PCR Beads (GE
Healthcare Life Sciences, Pittsburgh, PA). A 5-ml sample of the
DNA eluates were added to a solution containing 18 ml of water,
1 ml of each primer and the PuReTaq bead. Three ml of each PCR
was stained with ethidium bromide, electrophoresed in 2%
agarose for 40 minutes at 20 v/cm, and visualized under UVlight. None of the negative controls amplified (figs. 2–3). All PCRproducts were then purified using ExoSap-IT (Affymetrix Inc.,
Santa Clara, CA). Out of 16 PCR reactions for the Maiden, 8
were positive (see fig. 2). Out of 7 PCR reactions for the boy, all
were negative (see fig. 3). All products were sequenced using the
ABI prism BigDye Terminator Cycle Sequencing kit (Applied
Biosystems, Carlsbad, CA) and analyzed on an ABI 377A
automated sequencer. Of the 8 positive PCR reactions, 2 were
successfully sequenced (PCR samples 6 and 11; see fig. 2). Sample
6 and 11, both from the Maiden, were amplified and successfully
sequenced from two of the ZyGEM-extracted buccal samples.

Quantitative Analyses of Proteomic Profiles
A key challenge in analyzing proteomic profiles is identifying
adequate controls to establish correspondence with a particular
response, or departure from a baseline state. This challenge is
magnified for ancient samples, as differential protein degradation
could contribute to generating profiles significantly different from
current healthy or infected samples. To determine that the
expression profile consistent with active infection was not the result
of differential protein degradation, we used the expression profile
of the boy as a control. We used the spectral counts of the cloth
sample from the boy because many more proteins were recovered
from this sample than from the boy’s mouth swab (table S2). We
did not assume the boy’s sample represented a healthy individual
because that mummy showed signs of trauma and bleeding.
However, the boy showed no signs of respiratory disease (see
below), and therefore contrasted with the Maiden in that respect.
To compare the samples we used nonparametric statistics, as
the frequency distributions of spectral counts were highly skewed
and there was no basis for computing expected spectral
frequencies (e.g., [25,26]). We divided the proteins recovered into
two categories: those involved in inflammatory and immune
response, and all others. The spectral counts for the Maiden and
the boy were then compared using the Wilcoxon Mann-Whitney
test [27], with exact computation of the null distribution of the Z
statistic and breaking observed rank ties. The test was implemented in the wilcox_test routine in the coin v.1.0-20 [28] R [29]
package. If the proteomic profile of the Maiden corroborated
respiratory infection, then the spectral counts of inflammatory and
immune response proteins should be significantly elevated relative
PLoS ONE | www.plosone.org
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Table 1. Primers used for PCR amplification from DNA extracted from swab samples.

Name

Primer sequence

Prod. Size (bp)

Organism

Region

References

PANMYCF
PANMYCR

TGGATCCGACGAAGTCGTAACAAGG

270–400

Genus-wide Mycobacterium

16S rRNA

31

TGGATAGTGGTTGCGAGCAT

270–401

Genus-wide Mycobacterium

16S rRNA

31

MACF

CCCTGAGACAACACTCGGTC

144

Mycobacterium avium–
specific

16S rRNA

31

MACR

GTTCATCGAAATGTGTAATT

144

Mycobacterium avium–
specific

16S rRNA

31

Tb-A

CTCGTCCAGCGCCGCTTCGG

123

Mycobacterium tuberculosis
specific

MTP40

30

Tb-B

CCTGCGAGCGTAGGCGTCGG

123

Mycobacterium tuberculosis
specific

MTP41

30

Tb 11

ACCAACGATGGTGTGTCCAT

441

Genus-wide Mycobacterium

Heat-shock
protein 65
(hsp65)

30

Tb 12

CTTGTCGAACCGCATACCCT

441

Genus-wide Mycobacterium

Heat-shock
protein 65
(hsp65)

30

doi:10.1371/journal.pone.0041244.t001

unique-sequence subset of 63 taxa was resampled 100 times to
generate the phylogeny used in comparisons (fig. 4).
To investigate the probability of misidentifying the sequences,
we compared the likelihood of alternative phylogenies by
examining Bayesian posterior probabilities (BPP) and using the
approximately unbiased and the weighted Shimodaira-Hasegawa
tests [40]. The BPP and significance of tests of alternative
phylogenies were calculated by resampling site log-likelihoods in
consel v1.19 [41]. Site log-likelihoods for alternative phylogenies
were obtained using the baseml algorithm in paml v4.3 [42]. The
phylogenies compared are summarized in fig. 5, and comprise
alternative placements of the sequences obtained to rule out crosscontamination (sequences group with each other), or to locate the
sequences more precisely in the phylogeny. The complete results
of log-likelihood comparisons are shown in table 2.

Sample 11 yielded a 275-bp Mycobacterium sp. 65-kDa heat-shock
protein gene sequence, and sample 6 yielded a 440-bp
Bifidobacterium sp. 65-kDa heat-shock protein gene sequence.
We identified these sequences using a phylogenetic approach.
After initial queries to GenBank matched accessions in the phylum
Actinobacteria only, the bidirectional consensus of each of the two
fragments was matched against the NCBI reference genomes of
Actinobacteria
(http://www.ncbi.nlm.nih.gov/sutils/
genom_table.cgi) using BLAST [32]. The sequences significantly
matched accessions in each case (e-value #5e-140 for a 440-bp
sequence, and e-value #3e-81 for a 276-bp sequence). DNA
sequences corresponding to the 65-kDa heat-shock protein genes
from the top 50 hits were downloaded and aligned using the linsi
algorithm with 1000 iterations in mafft v6.710b [33,34]. The
inclusion of both sets of 50 top hits resulted in an alignment of 74
sequences across 1,759 nucleotides, including the two fragments
amplified. This alignment was analyzed using the high-performance computing maximum likelihood algorithm on RAxML
v7.0.4 [35,36], and applying a general time reversible model of
nucleotide evolution [37] with a discrete approximation to the
shape of a continuous gamma distribution for variable rates of
change across the alignment [38]. The full alignment was
resampled 1000 times to generate bootstrap branch support
values [39]. Many accessions were found to be identical, so the

Results
Computed tomography (CT) scanning and radiological examinations of the Maiden revealed that all her organs, including the
eyes and the brain, were intact [17]. Both radiological and visual
examination revealed pathologies consistent with a range of
infectious diseases: 1) a radiolucent area in the upper lobe of the
right lung, 2) a mucosal enlargement of the left maxillary sinus
consistent with sinusitis, 3) a zoster-like lesion on the right calf, and

Figure 2. Gel electrophoresis from the Maiden. Gel electrophoresis (2%) showing the amplification of the Mycobacterium sp. hsp65 gene
fragments in the Maiden’s buccal swab samples 6 and 11, both sequenced successfully. The image was inverted to facilitate detection of bands and
no other image treatment was performed. Sample 16 did not produce a satisfactory sequence. Samples 3 and 4 were positive for primers described
as specific to Mycobacterium avium, but did not produce satisfactory sequences. Sample 1 and 7 were positive for primers described as specific to
Mycobacterium tuberculosis, but did not produce satisfactory sequences. The negative controls are in lanes 17, 18, 19 and 20. Ladders are 100-bp
Fisher exACTgene.
doi:10.1371/journal.pone.0041244.g002
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infection. The external visible symptoms and the gamut of
immune response proteins obtained from the mouth swab
supported the hypothesis of pulmonary infection caused by
Mycobacterium.
The boy did not show signs of upper respiratory or pulmonary
infections based on CT-scans and radiology analyses, despite the
presence of blood in the mouth swab and cloth samples. For
these reasons, we inferred that the boy did not have a respiratory
infection, and the presence of blood was the result of trauma.
Proteomic analysis of the boy’s mouth swab revealed that his a-1
antitrypsin levels were high, and neutrophil defensin levels were
low. These results supported the inference that the boy was not
suffering from a lung infection (see table S2). The comparison of
the spectral counts in the inflammatory/immune category was
highly significant (Z = 23.16, P-value = 0.0003), while the comparison for all other proteins was not significant (Z = 0.3602, Pvalue = 0.7206). Inflammatory and immune response proteins
were elevated in the Maiden (median spectral count = 44.00
sd = 27.03) relative to the boy (median spectral count = 0.00
sd = 2.14). Levels of all other proteins detected in the samples
were similar (median spectral count of Maiden = 7.00
sd = 273.33; for the boy = 10.50 sd = 274.16).
To determine the etiology of the disease, we amplified the heatshock protein (hsp65) gene using Mycobacteria-specific primers
[30,58] and DNA extracted from the mouth swab taken from
lips of the Maiden. The PCR assay followed by direct sequencing
of PCR products confirmed the presence of Mycobacterium sp. in one
of the mouth swab samples, as well as the presence of nonpathogenic Bifidobacterium sp. (fig. 2). The presence of Bifidobacterium
sp. on the lips of the Maiden cannot be a result of fluid deposition
during decomposition, since the bodies of the children of
Llullaillaco did not decompose. We interpreted the detection of
Bifidobacterium sp. as an indication of vomit shortly prior to her
death, rather than as a result of postmortem contamination.
The position of the recovered sequence at the base of the
Mycobacterium genus could be caused by the large amounts of
missing data in the sequence (84%) relative to the genomic
sequences (alignment was 1,759-bp long). Based on the best
phylogeny (fig. 4), we compared alternative trees seeking to further
refine the placement of our sequence (fig. 5). These comparisons
ruled out cross-contamination of the Mycobacterium sp. sequence
with DNA from non-pathogenic Bifidobacterium sp. (P#0.002), as
well as the sequence corresponding to the non-pathogenic
Mycobacterium smegmatis complex (Bayesian posterior probability
[BPP] = 0.008, more conservative approximately unbiased [AU]
and weighted Shimodaira-Hasegawa [WSH] tests P$0.117), but
could not rule out the recovered sequence belonging to the
pathogenic
Mycobacterium
avium-bovis-tuberculosis
complex
(BPP = 0.230, AU and WSH P$0.475). The phylogenetic analyses
indicate a higher probability for the hypothesis that the sequence
corresponded to the pathogenic Mycobacterium avium-bovis-tuberculosis
than to the non-pathogenic Mycobacterium clade (fig. 5D).

Figure 3. Gel electrophoresis from the boy. Gel electrophoresis
(2%) showing the products of PCR amplification from samples from the
boy. The results were negative: no amplification bands could be
detected. The image was inverted, and contrast was increased to
facilitate detection of bands. No other image treatment was performed.
Lanes 1 and 2 were amplified with M. tuberculosis-specific primers, lanes
3 and 4 with the Mycobacterium-specific primers, and lanes 5, 6 and 7
were negative controls.
doi:10.1371/journal.pone.0041244.g003

4) streaks of mucus under both nostrils [20]. Similar exams on the
boy revealed no lesions, and no mucosal enlargement or other
signs of upper respiratory infection. To identify the proteins on the
lips of both mummies, and assess the presence of pathogens we
collected mouth swabs. Proteomics analyses of the mouth swabs
based on high-resolution mass spectrometry revealed the presence
of proteins expected in nasal secretions: serum proteins (i.e.
albumin, hemoglobin and serotransferrin) in both mummies. The
nasal mucus protein (PLUNC) level was three times higher in the
Maiden’s sample than in the boy’s.
In addition to serum proteins, we found several proteins that are
not normally present in blood or saliva, but are consistent with
host immune response to infectious disease in the Maiden’s sample
(see table 3). Cathepsin G is a specialized neutrophilic polymorphonuclear leukocyte serine protease found in the azurophil
granules and its function has been linked to pathogenesis of
diseases associated with inflammation and neutrophil infiltration of
the airways, such as bacterial COPD (Chronic Obstructive
Pulmonary Disease) [43,44,45,46,47,48]. Cathepsin G and neutrophil elastase have also been found in neutrophil extracellular
traps (NETs) that degrade virulence factors and kill bacteria [49].
A marker of chronic lung inflammatory diseases, a-1 antitrypsin, is
a strong indicator of mycobacterial infection [50,51,52,53]. It
protects tissues against inflammatory, cytotoxic proteases, such as
those from neutrophils. Neutrophil defensin 1 and 3 are part of the
defensin family of cysteine-rich cationic proteins found in
leukocytes and are specifically associated with macrophages
involved in lung tissue inflammation response [54].
The proteomic analysis of the Maiden sample also uncovered
two groups of proteins consistent with severe inflammation of the
lungs. The first group of proteins included S100 A8/A9,
apolipoprotein A1 and A2, and transthyretin. The second group
of proteins included vitamin-D-binding protein (VDB), serine
protease inhibitor (SERPIN) and transthyretin (TTR). The first
proteins are commonly expressed in chronic and acute lung
inflammations, and have been used as monitoring biomarkers for
pulmonary related diseases [55,56]. The second group of proteins
is also involved in acute lung inflammation, specifically in
mycobacterial infections [57]. The presence of the full complement of these proteins in the mouth swab of the Maiden provided
strong evidence of response to a severe respiratory bacterial
PLoS ONE | www.plosone.org

Discussion
Ancient Andean people suffered from mycobacterial infections,
as demonstrated by the presence of these pathogens in several
Inca mummies preserved at the American Museum of Natural
History [30]. However, mycobacteria such as Mycobacterium
tuberculosis have the ability to persist for long periods of time
without causing infection [59,60]. Therefore, detecting the
presence of the pathogen does not always indicate an active
infection. In this study, we provide direct evidence of active antibacterial immune response at the time of death in a 500-year-old
5

July 2012 | Volume 7 | Issue 7 | e41244

Pathogen Detection Using Proteomics

Figure 4. Maximum likelihood phylogeny. Maximum likelihood phylogeny and bootstrap support values based on 1000 pseudoreplicates of the
alignment of hsp65 gene nucleotide sequences. Sequences generated from the Maiden’s swab samples are shown in bold, larger font, and marked
with an asterisk.
doi:10.1371/journal.pone.0041244.g004

include characterizing the physiological state of the source of
blood in criminal cases. This technique offers a way of ascertaining
whether or not an individual was sick as a result of an infection by
a specific pathogen, rather than just carrying it in a latent form.
Forensic proteomics offers a sensitive but less contamination-prone
alternative to PCR amplification when dealing with ancient or
partially degraded biological samples [4,11,62,63]. Until now,
immunoassays had been the only way to detect active immune
response and infer infection in historical samples, but these were
plagued by low specificity and sensitivity. Shotgun proteomics can
play a critical role in pathological determination of the cause of
disease or death in archeological, medical, and criminal cases.

mummy. This response was significantly different from that of a
putatively healthy individual preserved for the same period of
time and under similar conditions. Initial radiological examination of the Maiden’s lungs showed pathological features such as
over-inflation and trapped air in some areas [20], which are
commonly documented in CT scans of patients affected by
mycobacterial infections, and specifically the Mycobacterium avium
and tuberculosis complexes [61].
The use of shotgun proteomics to detect protein remnants from
ancient body fluids has many potential applications in historical
and criminal sciences. We focused on samples from swabs from an
archaeological specimen, but potential forensic applications
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Figure 5. Alternative phylogenies compared to the best phylogeny. Alternative phylogenies compared to the best phylogeny obtained
through maximum likelihood analyses of DNA sequence data from the Maiden’s swab samples (fig. 4) using Bayesian posterior probabilities,
approximately unbiased, and weighted Shimodaira-Hasegawa tests. See table 2 for description of each alternative and test results.
doi:10.1371/journal.pone.0041244.g005

Table 2. Maximum likelihood, Bayesian posterior probability (BPP), and significance of alternative phylogenies (for numbering, see
fig. 5) using the approximately unbiased (AU) and weighted Shimodaira-Hasegawa (WSH) tests.

Phylogeny

Description

Maximum likelihood

BPP

AU

WSH

Fig. 4

Best phylogeny

233513.8

0.762

0.652

0.982

Fig. 5A

Both sequences at base of Bifidobacterium

233568.1

2E-24

0.001

0.002

Fig. 5B

Both sequences at base of Mycobacterium

233560.2

6E-21

3E-04

0.001
0.574

Fig. 5C

Mycobacterium sp. sequence part of smegmatis complex

233518.3

0.008

0.117

Fig. 5D

Mycobacterium sp. sequence part of avium-bovis-tuberculosis complex

233515.0

0.230

0.475

0.907

247198.4

0.000

3E-78

0.000

Random
doi:10.1371/journal.pone.0041244.t002
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Table 3. Immune system proteins and their respective accession numbers in the swab sample of the Maiden identified by mass
spectrometry.

Locus

Protein ID and description (SWISS-PROT)

Unique Peptides

Spectrum Count

Sequence Coverage

IPI00291410

Q8TDL5-1 C20orf114 Isoform 1 of Long palate, lung
and nasal epithelium carcinoma-associated protein 1

2

4

4.30%

IPI00005721

P59665 DEFA1;DEFA1B Neutrophil defensin 1

9

22

31.90%

IPI00021827

P59666 DEFA3 Neutrophil defensin 3

9

22

31.90%

IPI00028064

P08311 CTSG Cathepsin G

7

12

29.00%

IPI00027769

P08246 ELANE Neutrophil elastase

4

6

11.60%

IPI00007047

P05109 S100A8 Protein S100-A8

9

20

51.60%

IPI00027462 (IPI00939362)

P06702 S100A9 Protein S100-A9

10

20

35.10%

IPI00553177 (IPI00790784)

P01009-1 SERPINA1 Isoform 1 of Alpha-1-antitrypsin

5

6

14.40%

IPI00021841

P02647 APOA1 Apolipoprotein A-I

4

5

19.90%

IPI00021854

P02652 APOA2 Apolipoprotein A-II

7

10

62.00%

IPI00022432 (IPI00646384;
IPI00855916; IPI00940791)

P02766 TTR Transthyretin

3

4

22.40%

IPI00555812 (IPI00954102)

P02774-1 GC Isoform 1 of Vitamin D-binding protein

2

3

3.80%

IPI00218918 (IPI00549413)

P04083 ANXA1 Annexin A1

4

5

21.40%

Numbers in the last three columns indicate the number of unique peptides, the number of spectra observed and the sequence coverage for that particular protein (for a
full list see supplemental table S1).
doi:10.1371/journal.pone.0041244.t003
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